subscribeSubscribe
price-trendAsk Us
BioAdaptives Announces Initial Investigation Results on Pluripain

BioAdaptives Announces Initial Investigation Results on Pluripain
GLOBENEWSWIRE
24 Feb 2022
Share Share
Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA

Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA
PR NEWSWIRE
27 Dec 2017
Share Share
EMA’s PRAC Seeks to Suspend Four Imaging Agents

EMA’s PRAC Seeks to Suspend Four Imaging Agents
Zachary Brennan RAPS
17 Mar 2017
Share Share
Celgene Announces Positive Phase 3 Study Results for MS Drug Ozanimod

Celgene Announces Positive Phase 3 Study Results for MS Drug Ozanimod
Celgene Corporation DDDMAG
17 Feb 2017
Share Share